|
ZNF805 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.31600000014198E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.45949999980277E-07 |
| Normal-vs-Stage2 |
1.122160E-02 |
| Normal-vs-Stage3 |
3.381900E-04 |
| Normal-vs-Stage4 |
1.897240E-03 |
| Stage1-vs-Stage2 |
6.753200E-01 |
| Stage1-vs-Stage3 |
9.417600E-01 |
| Stage1-vs-Stage4 |
4.866400E-01 |
| Stage2-vs-Stage3 |
7.617400E-01 |
| Stage2-vs-Stage4 |
9.502400E-01 |
| Stage3-vs-Stage4 |
6.664400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01470000016357E-07 |
| Normal-vs-AfricanAmerican |
3.115800E-02 |
| Normal-vs-Asian |
1.279720E-03 |
| Caucasian-vs-AfricanAmerican |
5.637700E-02 |
| Caucasian-vs-Asian |
2.832200E-01 |
| AfricanAmerican-vs-Asian |
4.822400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.52730000005474E-06 |
| Normal-vs-Female |
2.58460000002181E-06 |
| Male-vs-Female |
6.822400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.401100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.8587999994768E-07 |
| Normal-vs-Age(61-80Yrs) |
1.95721999999288E-05 |
| Normal-vs-Age(81-100Yrs) |
5.749800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.342400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.374600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.235960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.533040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.899600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.522200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.396500E-04 |
| Normal-vs-Grade 2 |
1.93360000233511E-08 |
| Normal-vs-Grade 3 |
5.379800E-04 |
| Normal-vs-Grade 4 |
4.497900E-03 |
| Grade 1-vs-Grade 2 |
6.374400E-01 |
| Grade 1-vs-Grade 3 |
1.903400E-01 |
| Grade 1-vs-Grade 4 |
1.550990E-01 |
| Grade 2-vs-Grade 3 |
1.770420E-02 |
| Grade 2-vs-Grade 4 |
1.770760E-01 |
| Grade 3-vs-Grade 4 |
7.348600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.02219999529052E-08 |
| Normal-vs-ccB subtype |
2.41500000000006E-05 |
| ccA subtype-vs-ccB subtype |
5.295000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6212199999921E-05 |
| Normal-vs-N1 |
3.893600E-01 |
| N0-vs-N1 |
6.530300E-02 |
|
|
